Literature DB >> 6980224

Cerebral oxygen metabolism and blood flow in human cerebral ischemic infarction.

G L Lenzi, R S Frackowiak, T Jones.   

Abstract

Fifteen patients with acute cerebral hemispheric infarcts have been studied with positron emission tomography and the oxygen-15 steady-state inhalation technique. Thirteen follow-up studies were also performed. The values of cerebral oxygen metabolism (CMRO2), cerebral blood flow (CBF), and oxygen extraction ration (OER) have been calculated for the infarcted regions, their borders, the symmetrical regions in contralateral cerebral hemispheres, and the cerebellar hemispheres. This study demonstrates that in the completed stroke there are thresholds for regional CMRO2 and regional CBF below which the general clinical outcome of the patients is usually poor. The ischaemic lesions invariably produce an uncoupling between the greatly decreased metabolic demand and the less affected blood supply, with very frequent instances of relative hyperperfusion. Remote effects of the hemispheric infarcts have been demonstrated, such as crossed cerebellar diaschisis and contralateral transhemispheric depression. The level of consciousness correlates with oxygen uptake and blood flow both in the posterior fossa and in the contralateral cerebral hemispheres. The follow-up studies of individual patients underline the high variability of metabolism-to-flow balance during the acute phase of the illness, and stress the need for more studies focused on repeated assessments of homogeneous patient populations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6980224     DOI: 10.1038/jcbfm.1982.33

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  43 in total

Review 1.  The development, past achievements, and future directions of brain PET.

Authors:  Terry Jones; Eugenii A Rabiner
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

2.  Topographic EEG mapping in cerebrovascular disease.

Authors:  K Nagata
Journal:  Brain Topogr       Date:  1989 Fall-Winter       Impact factor: 3.020

Review 3.  The role of microthrombi and microcirculatory factors in localization and evolution of focal cerebral ischemia.

Authors:  N Heye; C Paetzold; J Cervós-Navarro
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

4.  99mTc-hexamethylpropylene amine oxime SPECT and X-ray CT in acute cerebral ischaemia.

Authors:  M Feldmann; E Voth; D Dressler; T Henze; K Felgenhauer
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

5.  Early venous drainage after successful endovascular recanalization in ischemic stroke -- a predictor for final infarct volume?

Authors:  F Dorn; A Kuntze-Soderqvist; S Popp; H Lockau; B Haller; C Zimmer; T Andersson; T Liebig
Journal:  Neuroradiology       Date:  2011-10-21       Impact factor: 2.804

6.  Age and energy intake interact to modify cell stress pathways and stroke outcome.

Authors:  Thiruma V Arumugam; Terry M Phillips; Aiwu Cheng; Christopher H Morrell; Mark P Mattson; Ruiqian Wan
Journal:  Ann Neurol       Date:  2010-01       Impact factor: 10.422

Review 7.  Topographic EEG in brain ischemia--correlation with blood flow and metabolism.

Authors:  K Nagata
Journal:  Brain Topogr       Date:  1988       Impact factor: 3.020

Review 8.  Heterogeneity in the penumbra.

Authors:  Gregory J del Zoppo; Frank R Sharp; Wolf-Dieter Heiss; Gregory W Albers
Journal:  J Cereb Blood Flow Metab       Date:  2011-07-06       Impact factor: 6.200

9.  Hyperemia following aneurysmal subarachnoid hemorrhage: incidence, diagnosis, clinical features, and outcome.

Authors:  Ralf Dirk Rothoerl; Chris Woertgen; Alexander Brawanski
Journal:  Intensive Care Med       Date:  2004-04-09       Impact factor: 17.440

10.  A study of acetazolamide-induced changes in cerebral blood flow using 99mTc HMPAO SPECT in patients with cerebrovascular disease.

Authors:  S Asenbaum; A Reinprecht; T Brücke; S Wenger; I Podreka; L Deecke
Journal:  Neuroradiology       Date:  1995-01       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.